Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Single-Dose vs. 3-day Azithromycin in the Treatment of Atypical Pneumonias: Preliminary Results - Poster abstracts (CROSBI ID 484313)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa

Schönwald, Slavko ; Kuzman, Ilija ; Škerk, Višnja ; Burek, V. ; Čulig, J. ; Orešković, K. Single-Dose vs. 3-day Azithromycin in the Treatment of Atypical Pneumonias: Preliminary Results - Poster abstracts // The Third International Conference on the Macrolides, Azalides and Streptogramins. 1996. str. 24, No 2.17-x

Podaci o odgovornosti

Schönwald, Slavko ; Kuzman, Ilija ; Škerk, Višnja ; Burek, V. ; Čulig, J. ; Orešković, K.

engleski

Single-Dose vs. 3-day Azithromycin in the Treatment of Atypical Pneumonias: Preliminary Results - Poster abstracts

An open, randomized study was designed to compare the efficacy and tolerability of single 1.5 g dose of azithromycin (group I) with standard 3-day, 500 mg daily, azithromycin regimen (group II) in the treatment of atypical pneumonia. Up to now, 37 patients (17 in group I and 20 in group II) completed the study and were included in this report. Clinical diagnosis of atypical pneumonia was confirmed by chest X-ray. Serological tests for atypical pathogens were positive in 11 patients in each group: Mycoplasma pneumoniae in 7 and 7, Chlamydia psittaci in 2 and 1, Coxiella burnetii in 1 and 1, Legionella pneumophila in 1 and 2 patients in group I and group II respectively. In remaining 15 patients all serological tests were negative. In both treatment groups all patients became afebrile within 72 hours after treatment with disappearance of symptoms and signs of pneumonia and partial or complete regression of chest X-ray abnormalities within 2 weeks. Tolerability of both dosing regimens was very good and there were no side-effects. Clinically insignificant increase of liver enzymes was observed in 5 and eosinophilia in 1 patient. These preliminary results suggest that standard total dose of azithromycin (1.5 g) may be given as single dose for the outpatient treatment of atypical pneumonia.

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

24, No 2.17-x.

1996.

objavljeno

Podaci o matičnoj publikaciji

The Third International Conference on the Macrolides, Azalides and Streptogramins

Podaci o skupu

The Third International Conference on the Macrolides, Azalides and Streptogramins

poster

24.01.1996-26.01.1996

Lisabon, Portugal

Povezanost rada

nije evidentirano